# The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

> **NCT04992026** · PHASE2 · COMPLETED · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 130 (actual)

## Conditions studied

- Prostatectomy
- Oligometastatic Prostate Cancer
- Abiraterone

## Interventions

- **PROCEDURE:** robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissection
- **DRUG:** 1.Abiraterone Acetate Tablets
- **DRUG:** Prednisone Acetate Tablets
- **DRUG:** Luteinizing Hormone-Releasing Hormone Analog

## Key facts

- **NCT ID:** NCT04992026
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-02
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992026, "The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04992026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*